Connecting telomere maintenance and regulation to the developmental origin and differentiation states of neuroblastoma tumor cells

Abstract excerpt

A cardinal feature that distinguishes clinically high-risk neuroblastoma from low-risk tumors is telomere maintenance. Specifically, neuroblastoma tumors with either active telomerase or alternative lengthening of telomeres exhibit aggressive growth characteristics that lead to poor outcomes, whereas tumors without telomere maintenance can be managed with observation or minimal treatment. Even though the need for...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Neuroblastoma Research and Treatments
• Share to PARP inhibition in cancer therapy
• Share to Telomeres, Telomerase, and Senescence